Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How much does marinol cost?Timolol ophthalmic gel coupon?Benefits of letrozole tablets?Wo2010020675a1 ribociclib synthesis patent?How much is travoprost without insurance?
See the DrugPatentWatch profile for Mifepristone
The U.S. Food and Drug Administration (FDA) approved mifepristone for medical termination of pregnancy. The initial approval was granted in 2000 [1]. Mifepristone is approved for use up to 70 days (10 weeks) of gestation [2].
The FDA first approved mifepristone in September 2000 [1].
Mifepristone is used in combination with misoprostol to end a pregnancy. The two medications are typically taken within the first 70 days of gestation [2].
The approved regimen involves taking 200 mg of mifepristone orally, followed by 800 mcg of misoprostol vaginally 24 to 48 hours later [2].
Misoprostol can be used alone for medical abortion, though it may be less effective than the mifepristone and misoprostol combination [3]. Surgical abortion is another option for ending a pregnancy [4].
Potential risks include heavy bleeding requiring surgery, ongoing pregnancy, and infection. Serious side effects are rare but can occur [5]. The FDA has approved Risk Evaluation and Mitigation Strategies (REMS) for mifepristone [6].
Mifepristone has faced legal challenges and varying regulatory actions in different U.S. states. However, the FDA's approval of mifepristone has been reaffirmed by courts, and the drug remains available [7].
Information on drug patents and exclusivity, including for medications like mifepristone, can often be found on resources like DrugPatentWatch.com [8].
The FDA's approval is based on clinical trials evaluating its safety and efficacy for the approved use. Long-term effects are generally considered in post-market surveillance and ongoing research [5].
The FDA approval process involves rigorous review of preclinical and clinical trial data to determine if a drug is safe and effective for its intended use [9]. This process ensures that the benefits of the drug outweigh its risks [9]. --- Sources: 1. https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-terminate-early-pregnancy 2. https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients-and-providers/questions-and-answers-about-medication-abortion 3. https://www.plannedparenthood.org/learn/abortion/medication-abortion 4. https://www.plannedparenthood.org/learn/abortion/surgical-abortion 5. https://www.fda.gov/medical-devices/abortion/medication-abortion-and-medications-abortion-using-mifepristone-and-misoprostol 6. https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients-and-providers/mifepristone-access-and-information 7. https://www.reuters.com/legal/government/us-supreme-court-weighs-whether-block-access-abortion-pill-mifepristone-2024-03-26/ 8. https://www.drugpatentwatch.com/ 9. https://www.fda.gov/about-fda/what-fda-does/how-fda-approves-drugs
Other Questions About Mifepristone :